Skip to main content
. 2019 Feb;58:17–24. doi: 10.1016/j.canep.2018.10.017

Table 2A.

Differences between the estimates of survival of the reference model with the one with the minimum AIC and BIC respectively, for females as a whole population (standardised), females in age-groups or females aged 55, 65, 75 and 85 by type of cancer.

Cancer Type Time (years) Standardised
 Group 1a
 Group 2a
 Group 3a
 Group 4a
 Group 5a
 55
 65
 75
 85
AIC BIC PP AIC BIC AIC BIC AIC BIC AIC BIC AIC BIC AIC BIC AIC BIC AIC BIC AIC BIC
Bladder 1 0.04 0.37 0.39 0.05 0.64 0.05 0.49 0.04 0.23 0.04 0.16 0.04 0.46 0.04 0.34 0.04 0.17 0.03 0.19 0.03 0.50
5 −0.01 −0.24 0.54 0.00 −0.61 0.00 −0.43 0.00 −0.10 0.00 0.05 −0.02 −0.35 0.00 −0.25 0.00 0.00 0.00 0.05 −0.02 −0.42
Lung 1 −0.24 −0.26 −0.05 −0.47 −0.47 −0.38 −0.38 −0.19 −0.19 −0.15 −0.16 −0.30 −0.33 −0.28 −0.28 −0.14 −0.14 −0.20 −0.22 −0.35 −0.38
5 0.06 0.07 0.22 0.10 0.09 0.05 0.04 −0.04 −0.05 −0.02 −0.02 0.16 0.18 −0.01 −0.01 −0.06 −0.06 0.05 0.06 0.22 0.24
Colon 1 −0.07 0.08 0.22 −0.23 0.24 −0.38 0.12 −0.46 0.01 −0.30 0.00 0.21 0.12 −0.45 0.06 −0.44 −0.01 −0.07 0.05 0.34 0.16
5 0.11 −0.08 0.40 0.08 −0.05 0.07 −0.03 0.05 −0.03 0.03 −0.06 0.18 −0.11 0.06 −0.03 0.04 −0.04 0.02 −0.09 0.23 −0.13
Rectum 1 0.03 −0.08 0.13 0.20 0.14 0.09 0.04 0.00 −0.04 −0.04 −0.12 0.07 −0.12 0.04 −0.01 −0.03 −0.08 −0.05 −0.15 0.09 −0.12
5 −0.09 −0.14 0.09 0.01 −0.07 −0.04 −0.11 −0.02 −0.08 0.11 0.07 −0.27 −0.30 −0.05 −0.11 0.03 −0.02 0.18 0.14 −0.45 −0.48
Breast 1 −0.16 −0.17 −0.08 −0.08 −0.06 −0.05 −0.06 −0.02 −0.07 −0.30 −0.13 −0.33 −0.44 0.05 −0.06 −0.23 −0.09 −0.17 −0.20 −0.18 −0.50
5 0.03 0.05 0.22 0.01 0.03 −0.10 0.03 0.45 0.02 −0.75 0.04 0.44 0.11 0.74 0.02 −0.62 0.03 0.17 0.05 0.99 0.13
Stomach 1 −0.10 0.03 −0.02 −2.43 −0.27 −1.63 −0.17 −0.84 −0.11 −0.17 −0.14 0.38 0.17 −1.21 −0.13 −0.49 −0.10 0.11 −0.18 0.48 0.23
5 0.20 −0.11 0.55 0.89 −0.13 0.56 −0.13 0.22 −0.07 −0.01 0.08 0.20 −0.20 0.38 −0.11 0.09 −0.02 −0.06 0.16 0.36 −0.40
Melanoma 1 −0.01 −0.01 0.11 0.00 0.00 −0.01 −0.01 0.03 0.03 0.06 0.06 −0.09 −0.09 0.01 0.01 0.05 0.05 0.06 0.06 −0.13 −0.13
5 0.00 0.00 0.15 0.02 0.02 0.03 0.03 0.04 0.04 0.03 0.03 −0.08 −0.08 0.03 0.03 0.04 0.04 0.01 0.01 −0.10 −0.10
Ovarian 1 −0.19 −0.13 0.04 0.36 0.06 0.03 0.00 −0.25 −0.13 −0.61 −0.28 −0.10 −0.16 −0.15 −0.05 −0.35 −0.21 −1.02 −0.32 0.47 −0.06
5 0.18 0.06 0.35 0.28 0.01 −1.25 0.08 0.90 0.17 0.69 0.19 −0.16 −0.13 −0.82 0.12 2.15 0.21 −1.71 0.10 1.11 −0.26
Hodgkins 1 −0.10 −0.10 0.28 −0.02 −0.02 −0.04 −0.04 −0.10 −0.10 −0.19 −0.19 −0.34 −0.34 −0.07 −0.07 −0.14 −0.14 −0.26 −0.26 −0.39 −0.39
5 −0.01 −0.01 0.01 −0.01 −0.01 −0.01 −0.01 −0.02 −0.02 −0.02 −0.02 0.00 0.00 −0.02 −0.02 −0.02 −0.02 −0.01 −0.01 0.00 0.00
a

The five groups used for the age-group estimates were 18–44, 45–54, 55–64, 65–74 and 75+.